IRADIMED CORPORATION (IRMD) Free cash flow 2016–2025
IRADIMED CORPORATION (IRMD) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$17.2MFY2025 · since FY2016: $8.6M → $17.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $17.2M | -2.5% |
| FY2024 | $17.6M | +192.5% |
| FY2023 | $6.0M | -34.7% |
| FY2022 | $9.2M | -14.4% |
| FY2021 | $10.8M | +100.5% |
| FY2020 | $5.4M | -45.5% |
| FY2019 | $9.9M | +38.0% |
| FY2018 | $7.1M | +170.7% |
| FY2017 | $2.6M | -69.4% |
| FY2016 | $8.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More IRMD financial trends
IRMD RevenueIRMD Net incomeIRMD Net marginIRMD Gross profitIRMD Gross marginIRMD Operating incomeIRMD Operating marginIRMD Operating cash flowIRMD Capital expendituresIRMD Return on equityIRMD Stock buybacksIRMD Dividends paidIRMD Total assetsIRMD Total liabilitiesIRMD Shareholders’ equityIRMD overview →